Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: BIOQUAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-03-19 to 2021-06-30
Current total value of award: $105275
Description: EO14042-IN-VIVO EFFICACY STUDY OF A NICLOSAMIDE PRODRUG IN A GOLDEN SYRIAN HAMSTER MODEL OF SARS-COV-2 (COVID-19). POP IS FOUR WEEKS FROM RECEIPT OF TEST ARTICLE COMPOUNDS.